BRD2 and obesity disorder: We further aimed to compare these findings to previous data on NAT availability in patients with severe obesity undergoing either conservative treatment program or RYGB surgery in order to provide novel insights on brain monoamine transporters beyond the dopamine system in obesity [7,8].